MYOTONIA
Clinical trials for MYOTONIA explained in plain language.
Never miss a new study
Get alerted when new MYOTONIA trials appear
Sign up with your email to follow new studies for MYOTONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug aims to ease muscle stiffness in rare disease
Disease control OngoingThis phase 3 study tests an experimental drug called AOC 1001 for myotonic dystrophy type 1, a genetic condition that causes muscle weakness and stiffness. About 159 adults who can walk independently are receiving either the drug or a placebo to see if it improves hand function, …
Matched conditions: MYOTONIA
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 12:06 UTC
-
New hope for DM1: Long-Term trial of AOC 1001 begins
Disease control ENROLLING_BY_INVITATIONThis study is for people with myotonic dystrophy type 1 (DM1) who have already taken part in earlier AOC 1001 trials. It aims to see if the drug is safe and works well over a longer period. About 230 adults will receive the medicine by IV and be monitored for side effects and ben…
Matched conditions: MYOTONIA
Phase: PHASE3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Space suit zaps muscles to keep astronauts fit
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a special body suit that uses mild electric pulses to stimulate muscles during exercise on the International Space Station. Eight astronauts will wear the suit during their workouts to see if it helps prevent muscle loss and stiffness in microgravity. Researchers…
Matched conditions: MYOTONIA
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Knowledge-focused
Last updated May 18, 2026 12:13 UTC